Literature DB >> 8527080

Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm-reduction programme.

A Peak1, S Rana, S H Maharjan, D Jolley, N Crofts.   

Abstract

OBJECTIVE: To measure changes in self-reported risk behaviour for HIV infections and HIV seroprevalence among injecting drug user (IDU) clients of an outreach harm-reduction programme in Kathmandu, Nepal.
METHODS: The Lifesaving and Lifegiving Society (LALS) of Kathmandu began providing sterile injecting equipment and education to Nepalese IDU in 1991. A sample of these IDU were interviewed and tested for HIV each year from 1991 through 1994.
RESULTS: Indicators of unsafe injecting fell, as knowledge of HIV rose more in 1994 for those who had been in touch with LALS for longer. Indicators of unsafe sex did not change. HIV seroprevalence remained low, 1.6% in 1991 and 0% in 1994.
CONCLUSION: We conclude that programmes for the prevention of HIV spread among IDU are possible and effective in Asia, and are urgently needed.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome--prevention and control; Asia; Behavior; Biology; Developing Countries; Diseases; Drug Usage; Hiv Infections--prevention and control; Iv Drug Users; Measurement; Nepal; Organization And Administration; Prevalence; Program Activities; Program Evaluation; Programs; Research Methodology; Risk Factors; Risk Reduction Behavior; Sampling Studies; Southern Asia; Studies; Surveys; Viral Diseases

Mesh:

Year:  1995        PMID: 8527080     DOI: 10.1097/00002030-199509000-00013

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  12 in total

Review 1.  A meta-analysis of the efficacy of HIV/AIDS prevention interventions in Asia, 1995-2009.

Authors:  Judy Y Tan; Tania B Huedo-Medina; Michelle R Warren; Michael P Carey; Blair T Johnson
Journal:  Soc Sci Med       Date:  2011-10-01       Impact factor: 4.634

Review 2.  Coverage of HIV prevention programmes for injection drug users: confusions, aspirations, definitions and ways forward.

Authors:  Mukta Sharma; Dave Burrows; Ricky Bluthenthal
Journal:  Int J Drug Policy       Date:  2007-01-02

3.  The Chinese government's response to drug use and HIV/AIDS: a review of policies and programs.

Authors:  Jianhua Li; Toan H Ha; Cunmin Zhang; Hongjie Liu
Journal:  Harm Reduct J       Date:  2010-03-05

4.  The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity.

Authors:  R B Oelrichs; I L Shrestha; D A Anderson; N J Deacon
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 5.  Syringe availability as HIV prevention: a review of modalities.

Authors:  P Coffin
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

Review 6.  HIV prevention among injecting drug users: responses in developing and transitional countries.

Authors:  A L Ball; S Rana; K L Dehne
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

Review 7.  Syphilis in drug users in low and middle income countries.

Authors:  Lara S Coffin; Ashley Newberry; Holly Hagan; Charles M Cleland; Don C Des Jarlais; David C Perlman
Journal:  Int J Drug Policy       Date:  2009-04-09

8.  Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study.

Authors:  Mohsen Vazirian; Bijan Nassirimanesh; Saman Zamani; Masako Ono-Kihara; Masahiro Kihara; Shahrzad Mortazavi Ravari; Mohammad Mehdi Gouya
Journal:  Harm Reduct J       Date:  2005-10-07

Review 9.  Combination prevention: new hope for stopping the epidemic.

Authors:  Sten H Vermund; Richard J Hayes
Journal:  Curr HIV/AIDS Rep       Date:  2013-06       Impact factor: 5.071

10.  Assessing and improving needle exchange programs: gaps and problems in the literature.

Authors:  Kate Ksobiech
Journal:  Harm Reduct J       Date:  2004-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.